Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of Induced Pluripotent Stem Cells From Patients With Best Disease and Other Inherited Retinal Degenerative Diseases.

NCT02162953 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT02162953
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02162953 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of Induced Pluripotent Stem Cells From Patients With Best Disease and Other Inherited Retinal Degenerative Diseases.
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Completed
Start date
February 28, 2014
Completion date
December 31, 2022
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adult onset vitelliform macular dystrophy, autosomal dominant vitreoretinalchoroidopathy, best vitelliform macular dystrophy, bestrophinopathy, retinal disease